CARGO Therapeutics | S-3ASR:“知名成熟发行人”证券注册声明
CARGO Therapeutics | 4:持股变动声明-高管 Radhakrishnan Anup
CARGO Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Samsara BioCapital, L.P.(9.6%),Samsara BioCapital GP, LLC(9.6%)等
CARGO Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Janus Henderson Group plc(5.8%)
CARGO Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-T. ROWE PRICE ASSOCIATES, INC.(5.9%)
CARGO Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-RTW Investments, LP(9.99%),Roderick Wong, M.D.(9.99%)
CARGO Therapeutics | 424B3:募资说明书
CARGO Therapeutics | 10-Q:2024财年三季报
CARGO Therapeutics | 8-K:CARGO Therapeutics公布2024年第三季度财务业绩并提供业务最新情况
CARGO Therapeutics | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(5.5%)
CARGO Therapeutics | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(5.5%)
CARGO Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Red Tree Venture Fund, L.P.(4.6%),Red Tree GP, LLC(4.6%)等
CARGO Therapeutics | 4:持股变动声明-高管 Chapman Gina
CARGO Therapeutics | 4:持股变动声明-高管 Radhakrishnan Anup
CARGO Therapeutics | 144:拟议出售证券
CARGO Therapeutics | 144:拟议出售证券
CARGO Therapeutics | 424B3:募资说明书
CARGO Therapeutics | 10-Q:2024财年二季报
CARGO Therapeutics | 8-K:CARGO Therapeutics公布2024年第二季度财务业绩并提供业务最新情况
CARGO Therapeutics | 8-K:重大事件
暂无数据